Product
Placebo with Optejet
1 clinical trial
1 indication
Indication
PresbyopiaClinical trial
A Phase 3 Study of the Safety and Efficacy of 2% Pilocarpine Ophthalmic Spray Administered With the Optejet® Microdose Dispenser for Temporary Improvement of Near Vision in Adults With PresbyopiaStatus: Completed, Estimated PCD: 2022-09-20